Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years, HR 2.60, 95% CI ...

Based on the AVEROSS trial, apixaban was superior to aspirin in patients unsuitable for warfarin in stroke prevention in nonvalvular AF. There is a need to reconsider the benefits of using aspirin ...

Vitamin K-inhibiting anticoagulants, especially warfarin, have become standard treatment for reducing the incidence of strokes and systemic emboli in patients with nonvalvular atrial fibrillation ...

Binge drinking and possibly, moderate alcohol intake, may trigger atrial fibrillation. Caffeine intake does not appear to be a trigger; although, some doctors still recommend that patients with atrial ...

BACKGROUND: Bleeding after starting anticoagulation for atrial fibrillation (AF) may be the first sign of malignancy, ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

Rivaroxaban did not reduce the incidence of cognitive decline, stroke or transient ischemic attack (TIA) in patients younger than 65 with nonvalvular atrial fibrillation (AFib) and low risk for stroke ...

Proper body care, learning about specific triggers, and taking a more holistic approach to heart health can help you manage your condition. Atrial fibrillation (AFib) is the most common form of ...

Namely, many clinicians were unsure if they could prescribe DOACs in patients with some degree of VHD. 6, 7 Actually, although the initial RCTs that compared VKAs with DOACs in AF were conducted among ...

Introduction: There is continued unmet medical need for new medicines across countries especially for cancer, immunological diseases, and orphan diseases. However, there are growing challenges with ...